Russian Heart Failure Journal 2010year Problems and prospects of cardiac resynchronization therapy in patients with chronic heart failure


To access this material please log in or register

Register Authorize
2010/

Problems and prospects of cardiac resynchronization therapy in patients with chronic heart failure

Atroshchenko E. S.

Keywords: myocardial remodeling, resynchronization, CHF

DOI: 10.18087/rhfj.2010.2.1261

Nowdays indications for resinhroniziruyuschey therapy (RT) are well-defined in the most severe group of patients with CHF. But accumulated experience allows to pose the question of expanding the indications for RT, to identify responders and non-responders.
  1. Cleland JG, Daubert JC, Erdmann E et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med. 2005;352 (15):1539–1549.
  2. Valzania C, Gadler F, Erksson M et al. Electromechanical effects of cardiac resynchronization therapy during rest and stress in patiets with heart failure. Eur J Heart Fail. 2007;9 (6-7):644–650.
  3. Abraham WT, Fisher WG, Smith AL et al. Cardiac resynchronization in chronic heart failure. N Engl J Med. 2002;346 (24):1845–1853.
  4. Auricchio A, Stellbrink C, Sack S et al. Pasing Therapies in Congestive Heart Failure (PATH-CHF) Study Group. Long-term clinical effect of hemodynamically optimised cardiac resynchronization therapy in patients with heart failure and ventricular conduction delay. J Am Coll Cardiol. 2002;39 (12):2026–2033.
  5. Bristow MR, Saxon LA, Boehmer J et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med. 2004;350 (21):2140–2150.
  6. Cazeau S, Leclercq C, Lavergne T et al. Multisite stimulation in Cardio­myopathies (MUSTIC) Study Investigators. Effect of multisite biventricular pacing inpathients with heart failure and intraventricular conduction delay. N Engl J Med. 2001;344 (12):873–880.
  7. Vardas PE, Auricchio A, Blanc JJ et al. Guidelines for cardiac pacing and cardiac resynchronization therapy: The Task Force for Cardiac Pacing and Cardiac Resynchronization Therapy of the European Society of Cardiology. Developed in collaboration with the European Heart Rhythm Association. Eur Heart J. 2007;28 (18):2256–2295.
  8. Cleland JG, Daubert JC, Erdmann E et al. Longer-term effects of cardiac resynchronization therapy on mortality in heart failure [the CArdiac REsynchronization-Heart Failure (CARE-HF) trial extension phase]. Eur Heart J. 2006;27 (16):1928–1932.
  9. Lindner O, Vogt J, Baller D et al. Gobal and regional myocardial oxygen consumption and blood flou in severe cardiomyopathy with left bungle branch block. Eur J Heart Fail. 2005;7 (2):225–230.
  10. Lancellotti P, Mélon P, Sakalihasan N et al. Effect of cardiac resynchronization therapy on fuctional mitral regurgitation in heart failure. Am J Cardiol. 2004;94 (11):1462–1465.
  11. Turner MS, Bleasdale RA, Vinereanu D et al. Electrical and mechanical components of dyssynchrony in heart failure patients with normal QRS duration and left bundle branch block: impact of left and biventricular pasing. Circulation. 2004;109 (21):2544–2549.
  12. Wong SP, French JK, Lydon AM et al. Relation of left ventricular sphericity to 10‑yers survival after acute myocardial infarction. Am J Cardiol. 2004;94 (10):1270–1275.
  13. Donal E, Leclercq C, Linde C, Daubert JC. Effects of cardiac resynchronization therapy on disease progression in chronic heart failure. Eur Heart J. 2006;27 (9):1018–1025.
  14. Spragg DD, Leclercov C, Logmani M et al. Regional alterations in protein expression in the dyssynchronous failing heart. Circulation. 2003;108 (8):929–932.
  15. Kurita T, Onishi K, Dohi K et al. Impact of heart rate on mechanical dyssynchrony and left ventricular contractility in patients with heart failure normal QRS duration. Eur J Heart Fail. 2007;9 (6-7):637–643.
  16. Kourouklis S, Manolis AG. Cardiac resychronization therapy in asymptomatic and mildly symptomatic chronic systolic heart failure: A new era of systolic heart failure management? Hellenic J Cardiol. 200;49 (5):349–351.
  17. Andrikopoulos GK, Tzeis S, Manolis AS. Cardiac resynchronization therapy in heart failure patients with narrow QRS complex:quo vadis? Hellenic J Cardiol. 2007;48 (6):315–318.
  18. Karagiannis SE, Maounis T, Athanassopoulos GD et al. Cardiac resynchronization therapy decreases the mitral coaptation point displacement in heart failure patients. Hellenic J Cardiol. 2006;47 (4):198–205.
  19. Baldasseroni S, Gentile A, Gorini M et al. Intraventricular conduction defects in patients with congestive heart failure: left but not right bundle branch block is an independent predictor of prognosis. A report from the Italian Network on Congestive Heart Failure (IN-CHF database). Ital Heart J. 2003;4 (9):607–613.
  20. Kalra PR, Sharma R, Shamim W et al. Clinical characteristic and survival of patients with chronic heart failure and prolonged QRS duration. Int J Cardiol. 2002;86 (2-3):225–231.
  21. Yu CM, Bleeker GB, Fung JW et al. Left ventricular reverse remodeling but not clinical improvement predicts long-term survival after cardiac resynchronization therapy. Circulation. 2005;112 (11):1580–1586.
  22. Da Costa A, Thévenin J, Roche F et al. Prospective validation of stress echocardiography as an identifier of cardiac resynchronization therapy responders. Heart Rhythm. 2006;3 (4):406–413.
  23. Urheim S, Edvardsen T, Torp H et al. Myocardial strain by Dopper echocardiography. Validation of a new method to quantify regional myocardial function. Circulation. 2000;102 (10):1158–1164.
  24. Greenberg NL, Fistenberg MS, Castro PL et al. Doppler-derived myocardial systolic srain rate is a strong index of left ventricular contractility. Circulation. 2002;105 (1):99–105.
  25. Breithardt OA, Stellbrink C, Herbots L et al. Cardiac resyncronization therapy can reverse abnormal myocardial strain distribution in patients with heart failure and left bundle block. J Am Coll Cardiol. 2003;42 (3):486–494.
  26. Kanzaki H, Bazaz R, Schwartzman D et al. A mechanism for immediate reduction in mitral regurgitation after cardiac resynchronization therapy. J Am Coll Cardiol. 2004;44 (8):1619–1625.
  27. Mele D, Pasanisi G, Capasso F et al. Left intraventricular myocardial deformation dyssynchrony identifies responders to cardiac resynchronization therapy in patients with heart failure. Eur Heart J. 2006;27 (8):1070–1078.
  28. Yu CM, Chau E, Sanderson JE et al. Tissue Doppler echocardiographic evidence of reverse remodeling and improved synchronicity by simultaneously delaying regional contraction after biventricular pacing therapy in heart failure. Circulation. 2002;105 (4):438–445.
  29. Braunschweig F, Sörensen J, von Bibra H et al. Effects of biventricular pa­cing on myocardial blood flow and oxygen consumption using carbon-11 acetat positron emission tomography in patients with heart failure. Am J Cardiol. 2003;92 (1):95–99.
  30. Uemura T, Otsuji Y, Nakashiki K et al. Papillary muscle dysfunction attenu­ates ischemic mitral regurgitation in patients with localized basal inferior left ventricular remodeling: insights from tissue Doppler strain imaging. J Am Coll Cardiol. 2005;46 (1):113–119.
  31. Bleeker GB, Schalij MJ, Nihoyannopoulos P et al. Left ventricular dyssynchrony predicts right ventricular remodeling after cardiac resynchronization therapy. J Am Coll Cardiol. 2005;46 (12):2264–2269.
  32. Ghio S, Freemantle N, Serio A et al. Baseline echocardiographic characte­ristics of heart failure patients enrolled in a large Europen multicentre trial (Cardiac Resynchronisation Heart Failure Study). Eur J Echocardiogr. 2006;7 (5):373–378.
  33. Wikstrom G, Blomström-Lundqvist C, Andren B et al. The effects of aetio­logy on outcome in patients treated with cardiac resynchronization therapy in the CARE-HF trial. Eur Heart J. 2009;30 (7):782–788.
  34. Porciani MC, Macioce R, Dearchi G et al. Effects of cardiac resynchronization therapy on the mechanisms underlying functional mitral regurgitation in congestive heart failure. Eur. J. Echocardiogr. 200;7:31–39.
  35. Yu CM, Zhang Q, Fung JW et al. A novel tool to assess systolic asynchrony and identify responders of cardiac resynchronization therapy to tissue synchronization imaging. J Am Coll Cardiol. 2005;45 (5):677–684.
  36. Bleeker GB, Bax JJ, Fung JW et al. Clinical versus echocardiograhic parame­ters to assess response to cardiac resynchronization therapy. Am J Cardiol. 2006;97 (2):260–263.
  37. Duncan AM, Lim E, Clague J et al. Comparison of segmental and global markers of dyssynchrony in predicting clinical response to cardiac resynchronization. Eur Heart J. 2006;27 (20):2426–32.
  38. Parsai C, Bijnens B, Sutherland GR et al. Toward understanding response to cardiac resynchronization therapy: left ventricular dyssynchrony is only one of multiple mechanisms. Eur Heart J. 2009;30 (8):940–949.
  39. Higgins SL, Hummel JD, Niazi IK et al. Cardiac resynchronization therapy for the treatment of heart failure patients with intraventricular conduction delay and malignant ventricular tachyarrhythmias. J Am Coll Cardiol. 2003;42 (8):1454–1459.
  40. Abraham WT, Young JB, Leon AR et al. Effects of cardiac resynchronization on disease progression in patients with left ventricular systolic dysfunction, an indication for an implantable cardioverter-defibrillator, and mildly symptomatic chronic heart failure. Circulation. 2004;110 (18):2864–2868.
  41. Landolina M, Lunati M, Gasparini M et al. Comparison of the effects of cardiac resynchronization therapy in patients with class II versus class III and IV heart failure (from the InSync / InSync ICD Italian Registry). Am J Cardiol. 2007;100 (6):1007–1012.
  42. Cleland JG, Freemantle N, Daubert JC et al. Long-term effect of cardiac resynchronisation in patients reporting mild symptoms of heart failure: a report from the CARE-HF study. Heart. 2008;94 (3):278–283.
  43. Ng K, Kedia N, Martin D et al. The benefits of biventricular pacing in heart failure patients with narrow QRS, NYHA class II and right ventricular pa­cing. Pacing Clin Electrophysiol. 2007;30 (2):193–198.
  44. Pires LA, Abraham WT, Young JB et al. Clinical predictors and timing of NYHA class improvement with cardiac resynchronization therapy in patients with advanced chronic heart failure: results from the multicenter InSync randomized clinical evaluation (MIRACLE-ICD) trials. Am Heart J. 2006;151 (4):837–843.
  45. Linde C, Gold M, Abraham WT, Daubert JC; REVERSE Study Group. Rationale and design of a randomized controlled trial to assess the safety and efficacy of cardiac resynchronization therapy in patients with asymptomatic left ventricular dysfunction with previous symptoms or mild heart failure – the REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction (REVERSE) study. Am Heart J. 2006;151 (2):288–294.
  46. Moss AJ, Brown MW, Cannom DS et al. Multicenter automatic defibrillator implantation trial-cardiac resynchronization therapy (MADIT-CRT): design and clinical protocol. Ann Noninvasive Electrocardiol. 2005;10 (4 Suppl):34–43.
  47. Goscinska-Bis K, Bis J, Krejca M et al. Totally epicardial cardiac resynchronization therapy system implantation in patients with heart failure undergoing CABG. Eur J Heart Fail. 2008;10 (5):498–506.
  48. Gras D, Bocker D, Lunati M et al. Implantation of cardiac resynchronization therapy systems in the CARE-HF trial: procedural success rate and safety. Europace. 2007;9 (7):516–522.
  49. Song ZZ. Impact of left ventricular lead position in cardiac resynchronization therapy on left ventricular remodeling: a circumferential strain analysis based on 2D echocardiography. Eur Heart J. 2008;29 (5):684.
  50. Yu CM, Chan YS, Zhang Q et al. Benefits of cardiac resynchronization therapy for heart failure patients with narrow QRS complexes and coexis­ting systolic asynchrony by echocardiography. J Am Coll Cardiol. 2006;48 (11):2251–2257.
  51. Bigger JT Jr. Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary-artery bypass graft surgery. Coronary Artery Bypass Graft (CABG) Patch Trial Investigators. N Engl J Med. 1997;337 (22):1569–1575.
  52. Achilli A, Sassara M, Ficili S et al. Long-term effectiveness of cardiac resynchronization therapy in patients with refractory heart failure and «narrow» QRS. J Am Coll Cardiol. 2003;42 (12):2117–2124.
  53. Krebanek M, Malek I, Bitesnik J et al. Decrease in plasma B-type natriuretic peptide early after initiation of cardiac resynchronization therapy predicts clinical improvement at 12 month. Eur J Heart Fail. 2006;8 (8):832–840.
Atroshchenko E. S. Problems and prospects of cardiac resynchronization therapy in patients with chronic heart failure. Russian Heart Failure Journal. 2010;11(2):124-127.

To access this material please log in or register

Register Authorize
Ru En